It's Not Only About Inflammation Any More
Bruce Furie A lthough P-selectin had already been established as a vascular adhesion molecule critical in the inflammatory response, in 1992 Palabrica et al were the first to demonstrate that P-selectin also played a significant role in blood coagulation and thrombosis. 1 In these experiments using an arteriovenous shunt model of thrombosis in a baboon, anti-P-selectin antibodies were shown to block fibrin formation in the developing thrombus forming in a thrombogenic Dacron shunt. Shortly thereafter, P-selectin was not only shown to upregulate tissue factor generation in monocytes, 2 but also to initiate signaling pathways in leukocytes and activate the elaboration of cytokines in a mechanism that involved P-selectin interaction with its receptor, PSGL-1. 3, 4 A number of more recent reports have secured a role for P-selectin in hemostasis and thrombosis, including the demonstration that overexpression of P-selectin can induce a procoagulant state, 5 that circulating microparticles bearing PSGL-1, the counterreceptor for P-selectin, deliver tissue factor to the growing platelet thrombus via a mechanism dependent on P-selectin and PSGL-1, 6 and that procoagulant microparticles can partially correct the hemostatic defect in hemophilic mice. 7 The role of P-selectin and PSGL-1 along with microparticles has recently been reviewed. 8, 9 The current report by del Conde et al in this issue of Arteriosclerosis, Thrombosis, and Vascular Biology 10 adds yet another page to the growing list of mechanisms by which P-selectin can contribute to procoagulant activity.
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The current study demonstrates that the interaction of P-selectin with PSGL-1 on monocytes or monocyte-like cells is associated with the exposure of phosphatidylserine on the plasma membrane. This anionic phospholipid, normally oriented within the cell membrane to face internally, flips during cell activation to expose its head group externally. Because this phospholipid is essential for the formation of the Factor IXa/Factor VIIIa complex and the Factor Xa/Factor Va complex on cell membranes, it is widely accepted that the exposure of phosphatidylserine on the activated cell surface localizes the blood coagulation complexes to membranes in the region of vascular injury to the surfaces of cells that have been activated. The Gla domain of the vitamin K-dependent proteins requires phosphatidylserine for membrane recognition. Indeed, on binding of calcium ions to these proteins, the vitamin K-dependent proteins undergo a major conformation change with the exposure of a hydrophobic patch in the T loop of the N terminus of the Gla domain (which seats itself into the membrane) 11, 12 and the development of a binding site for the phosphatidylserine head group within the Gla domain of the protein. 13 As the authors indicate, the P-selectin-dependent exposure of phosphatidylserine on the monocyte surface takes place on a time scale of hours. 10 This is parallel to the kinetics of P-selectin-dependent tissue factor expression on monocytes. 2 These results again emphasize that that these mechanisms do not support physiological hemostasis because this host defense mechanism requires a response time of seconds or minutes. Rather, these processes are more likely contributors to the thrombotic tendencies associated with inflammation.
As is often the case in this line of work, the current results raise as many questions as they answer. Does this modest increase in phosphatidylserine significantly increase in vivo thrombin generation? Do activated monocytes provide a pathologically important surface for thrombin generation in vivo? These issues provide food for thought and possible directions of further investigation.
